Search Results 571-580 of 16950 for clindamycin

  1. A Study to Evaluate the Patterns of Use of Biological Agents and Risk Factors for Discontinuation of Agents in Pediatric Crohn’s Disease (CD) and Ulcerative Colitis (UC) within the Pediatric Population - Mayo Clinic

    This population will be queried for biologic use prior to age 18. The study population for the remainder of the study will be all CD and UC patients in ICN who ...

  2. Drugs and Supplements that Start with G - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “G” to learn about drug side effects, proper use and ...

  3. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  4. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  5. Antibiotic Therapies Clinical Trials - Mayo Clinic Research

    The microbiome within the gut lumen has been found in prior studies to differ in individuals with C. difficile infection (CDI) in comparison to those without ...

  6. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  7. Ravulizumab-cwvz (intravenous route) - Side effects & uses - Mayo Clinic

    Ravulizumab-cwvz injection is used to treat a type of blood disease called paroxysmal nocturnal hemoglobinuria (PNH). This medicine helps reduce red blood cell ...

  8. Hodgkin lymphoma (Hodgkin disease) - Doctors and departments - Mayo Clinic

    Learn how this cancer differs from other lymphomas. Find out about risk factors and treatments, such as chemotherapy, radiation and bone marrow transplant.

  9. Pharmacogenomics: Your Own Prescription - Mayo Clinic

    Each person's genetic code is unique. Researchers focused on pharmacogenomics at Mayo Clinic are working to understand how these tiny DNA variations cause ...

  10. A Study Comparing BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM) - Mayo Clinic

    This study is to evaluate the safety, efficacy and clinical benefit of BGB-3111 vs ibrutinib in subjects with MYD88 Mutation Waldenström's Macroglobulinemia.